Literature DB >> 11080523

Failure of baclofen to modulate discriminative-stimulus effects of cocaine or methamphetamine in rats.

P Munzar1, S W Kutkat, C R Miller, S R Goldberg.   

Abstract

The effects of baclofen, an agonist at GABA(B) receptors, were evaluated in rats trained to discriminate 10.0 mg/kg of cocaine or 1. 0 mg/kg of methamphetamine from saline under a fixed-ratio 10 schedule of food delivery. Baclofen (0.56-5.6 mg/kg) did not attenuate the discriminative-stimulus effects of the training dose of cocaine or methamphetamine and did not produce any shift in the cocaine and methamphetamine dose-response curves. Higher baclofen doses (3.0-5.6 mg/kg), however, markedly depressed or completely eliminated food-maintained responding. This suggests that previous reports of baclofen-induced decreases in cocaine self-administration behavior are connected, in some way, with either a general suppression of appetitive behaviors or with sedation and locomotor depression, rather than with any pharmacologically specific effect, and not accompanied by changes in subjective response to cocaine, as assessed by discriminative-stimulus measures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080523     DOI: 10.1016/s0014-2999(00)00772-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  GABAergic modulation of the discriminative stimulus effects of methamphetamine.

Authors:  M B Gatch; M Selvig; M J Forster
Journal:  Behav Pharmacol       Date:  2005-07       Impact factor: 2.293

3.  Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats.

Authors:  Małgorzata Filip; Małgorzata Frankowska; Magdalena Zaniewska; Anna Gołda; Edmund Przegaliński; Jerzy Vetulani
Journal:  Psychopharmacology (Berl)       Date:  2007-01-26       Impact factor: 4.530

4.  Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction.

Authors:  Valentina Vengeliene; Tatiane T Takahashi; Olga A Dravolina; Irina Belozertseva; Edwin Zvartau; Anton Y Bespalov; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2018-04-12       Impact factor: 4.530

5.  Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine.

Authors:  Wynne K Schiffer; Douglas Marsteller; Stephen L Dewey
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

6.  Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABA(B) receptors.

Authors:  Alessandro Orrù; Daniele Fujani; Chiara Cassina; Mirko Conti; Angelo Di Clemente; Luigi Cervo
Journal:  Psychopharmacology (Berl)       Date:  2012-03-13       Impact factor: 4.530

7.  Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates.

Authors:  Karen Brebner; Soyon Ahn; Anthony G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2004-07-22       Impact factor: 4.530

8.  Pavlovian discriminative stimulus effects of methamphetamine in male Japanese quail (Coturnix japonica).

Authors:  B Levi Bolin; Destiny L Singleton; Chana K Akins
Journal:  J Exp Anal Behav       Date:  2014-06-25       Impact factor: 2.468

9.  Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans.

Authors:  Joshua A Lile; William W Stoops; Timothy S Allen; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

10.  Effects of ethanol on cocaine discrimination in rats.

Authors:  Michael B Gatch; Bradley D Youngblood; Michael J Forster
Journal:  Pharmacol Biochem Behav       Date:  2003-07       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.